Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience

• Main Authors: A. Martínez-Doménech (Author), V. Zaragoza-Ninet (Author), A. Esteve-Martínez (Author), A. García-Rabasco (Author), J.L. Sánchez-Carazo (Author), A. Pérez-Ferriols (Author)
• Format: Book
• Published: Elsevier, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Dupilumab is a new targeted therapy for severe atopic dermatitis (AD) with limited real-world evidence. Objective: Explore our experience with dupilumab for AD in clinical practice at a tertiary care center. Material and method: Unicentric observational retrospective study including adul...